Literature DB >> 18481107

Congenital thrombotic thrombocytopenic purpura associated with unilateral moyamoya disease.

Hye Won Park1, Doyeon Oh, Namkeun Kim, Hee Yeon Cho, Kyung Chul Moon, Jong Hee Chae, Hyo Seop Ahn, Yong Choi, Hae Il Cheong.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy disorder associated with congenital or acquired deficiency of the von Willebrand factor-cleaving protease, ADAMTS13. The central nervous system and kidneys are the two major organs of involvement in TTP. Moyamoya (puff of smoke) disease is a cerebral arteriopathy of unknown etiology characterized by narrowing or occlusion of the distal internal carotid or proximal anterior or middle cerebral arteries, which causes the formation of multiple tiny collateral networks. We report here a case of an 11-year-old boy with unilateral moyamoya disease and congenital TTP. The patient had a history of severe neonatal jaundice and thereafter recurrent episodes of hemolytic anemia associated with renal dysfunction and cerebral infarction. The plasma ADAMTS13 activity of the patient <3% of normal, and ADAMTS13 gene analysis revealed an abnormal splicing mutation (c.330+1 G > A) in one allele and a novel missense mutation (p.Ile1217Thr) in the other. This is the first case of a genetically confirmed congenital TTP associated with unilateral moyamoya disease. Although the causal relationship between the two diseases has not been established, TTP may be included as one of the causes of moyamoya syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481107     DOI: 10.1007/s00467-008-0847-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.

Authors:  M Fukui
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

2.  The CUB domain. A widespread module in developmentally regulated proteins.

Authors:  P Bork; G Beckmann
Journal:  J Mol Biol       Date:  1993-05-20       Impact factor: 5.469

3.  Moyamoya disease and syndrome.

Authors:  H J Hoffman
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

4.  Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura.

Authors:  S Kinoshita; A Yoshioka; Y D Park; H Ishizashi; M Konno; M Funato; T Matsui; K Titani; H Yagi; M Matsumoto; Y Fujimura
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

5.  Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.

Authors:  M Furlan; R Robles; M Solenthaler; B Lämmle
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

6.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

7.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

8.  Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome.

Authors:  Masanori Matsumoto; Koichi Kokame; Kenji Soejima; Masayoshi Miura; Syuhei Hayashi; Yasuhiko Fujii; Asayuki Iwai; Etsuro Ito; Yoichiro Tsuji; Mayuko Takeda-Shitaka; Mitsuo Iwadate; Hideaki Umeyama; Hideo Yagi; Hiromichi Ishizashi; Fumiaki Banno; Tomohiro Nakagaki; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

9.  Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura.

Authors:  Toshihiro Uchida; Hideo Wada; Minoru Mizutani; Miho Iwashita; Hiroaki Ishihara; Toshiro Shibano; Misako Suzuki; Yumiko Matsubara; Kenji Soejima; Masanori Matsumoto; Yoshihiro Fujimura; Yasuo Ikeda; Mitsuru Murata
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

10.  Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.

Authors:  Koichi Kokame; Masanori Matsumoto; Kenji Soejima; Hideo Yagi; Hiromichi Ishizashi; Masahisa Funato; Hiroshi Tamai; Mutsuko Konno; Kei Kamide; Yuhei Kawano; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

View more
  3 in total

1.  [A 2-day-old neonate with hyperbilirubinemia and thrombocytopenia].

Authors:  Chen Li; Zheng Chen; Ming-Yan Chen; Xiao-Lu Ma
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-12

2.  Long term follow up of congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) on hemodialysis for 19 years: a case report.

Authors:  Koki Mise; Yoshifumi Ubara; Masanori Matsumoto; Keiichi Sumida; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Hayami; Tatsuya Suwabe; Junichi Hoshino; Naoki Sawa; Kenichi Ohashi; Koichi Kokame; Toshiyuki Miyata; Yoshihiro Fujimura; Kenmei Takaichi
Journal:  BMC Nephrol       Date:  2013-07-20       Impact factor: 2.388

Review 3.  A new horizon of moyamoya disease and associated health risks explored through RNF213.

Authors:  Akio Koizumi; Hatasu Kobayashi; Toshiaki Hitomi; Kouji H Harada; Toshiyuki Habu; Shohab Youssefian
Journal:  Environ Health Prev Med       Date:  2015-12-10       Impact factor: 3.674

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.